|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute on Drug Abuse (NIDA) |
|---|---|
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00061100 |
Purpose
The purpose of this study is to evaluate HIV counseling intervention for Methadone-Maintained Patients.
| Condition | Intervention | Phase |
|---|---|---|
|
Opioid-Related Disorders |
Behavioral: Behavior Therapy Behavioral: Education |
Phase I |
| Study Type: | Interventional |
| Study Design: | Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
| Official Title: | HIV Counseling Intervention for Methadone-Maintained Patients |
| Enrollment: | 50 |
| Study Start Date: | October 1999 |
| Study Completion Date: | October 2003 |
| Primary Completion Date: | October 2003 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1: Experimental
Targeted RISK intervention
|
Behavioral: Behavior Therapy |
|
2: Active Comparator
Education intervention
|
Behavioral: Education
Education
|
The purpose of this proposal is to evaluate, in methadone-maintained patients the association between an ADHD diagnosis and high-risk HIV/Hepatitis behavior. In addition, we would like to determine whether a new manually-guided HIV intervention; RISE: Reduce high risk Intravenous drug use and unsafe Sexual Encounters is superior to standard HIV/Hepatitis psycho-education.
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, New York | |
| Research Foundation for Mental Hygiene, Inc. | |
| New York, New York, United States, 10032 | |
| Principal Investigator: | Frances R Levin, M.D. | Research Foundation for Mental Hygiene, Inc. |
More Information
| Responsible Party: | NYSPI ( Frances R. Levin, M.D ) |
| Study ID Numbers: | NIDA-011444-2, R01-DA011444-2, DPMCDA |
| Study First Received: | May 21, 2003 |
| Last Updated: | October 15, 2009 |
| ClinicalTrials.gov Identifier: | NCT00061100 History of Changes |
| Health Authority: | United States: Federal Government |
|
Mental Disorders Substance-Related Disorders Disorders of Environmental Origin Opioid-Related Disorders |